Cyfuse Biomedical K.K. (TYO:4892)

Cyfuse Biomedical K.K. Revenue

Cyfuse Biomedical K.K. had revenue of 24.00M JPY in the quarter ending March 31, 2025, with 140.00% growth. This brings the company's revenue in the last twelve months to 68.00M, up 6.25% year-over-year. In the year 2024, Cyfuse Biomedical K.K. had annual revenue of 54.00M, down -11.48%.

• Revenue (ttm): 68.00M
• Revenue Growth: +6.25%
• P/S Ratio: 112.85
• Revenue / Employee: 3.24M
• Employees: 21
• Market Cap: 7.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	54.00M	-7.00M	-11.48%
Dec 31, 2023	61.00M	-313.00M	-83.69%
Dec 31, 2022	374.00M	-334.00M	-47.18%
Dec 31, 2021	708.00M	571.00M	416.79%
Dec 31, 2020	137.00M	15.19M	12.47%